Resultados de la búsqueda 461-470 of 20525 for Two-phase
The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...
... phase 2 dose (RP2D) of APG-2575. A Study to Evaluate Immunotherapy and Ovarian Function Among Pre-menopausal Melanoma Survivors. Rochester, Minn. The ...
In Part 2 Cohort 1, an expansion phase at the established RP2D will be undertaken in participants with selected advanced solid tumors. In Part 2 Cohort 2, a ...
This is a Phase 2 global, multi-center, open-label study to assess the ... In the phase II part, to evaluate the preliminary antitumor activity of two ...
... two future steps: A Study to Evaluate Droperidol Use in the Emergency ... phase 2 dose (RP2D) for future study after treatment with SONALA-001 in ...
... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...
... (Stage I and Stage II). Additinoally, to evaluate the effectiveness by ... This is an open-label, two-part Phase 2 study investigating CGT9486 for the ...
To accomplish this aim CREST-H will add on to the NINDS-sponsored CREST-2 trial (parallel, outcome-blinded Phase ... stage (PAF), and even at a prodromal stage ( ...
This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...
... 2 weeks) to see if the effects of the treatments are similar or better. Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?